• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Eagle Pharmaceuticals (NQ: EGRX )

    4.565 -0.575 (-11.19%)
    Streaming Delayed Price Updated: 12:07 PM EDT, Sep 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Eagle Pharmaceuticals

    < Previous 1 2 3 4 5 6 Next >
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, NATIONAL TRIAL LAWYERS, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EGRX
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    Kaplan Fox & Kilsheimer LLP Reminds Eagle Pharmaceuticals Investors of a Class Action and Upcoming Deadline
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    ROSEN, A RESPECTED AND LEADING FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX
    WHY: NEW YORK, NY - (NewMediaWire) - January 07, 2024 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Eagle... 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, A LEADING LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    EAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Eagle Pharmaceuticals, and Golden Heaven and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EGRX
    From Rosen Law Firm
    Via Business Wire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Eagle Pharmaceuticals, and Golden Heaven and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors and Encourages Investors to Contact the Firm Before February 9, 2024
    From Kirby McInerney LLP
    Via Business Wire
    EAGLE PHARMACEUTICALS SHAREHOLDER ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eagle Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Robbins LLP Reminds Investors of Eagle Pharmaceuticals, Inc. that There is Still Time to Move for Lead Plaintiff in the EGRX Class Action
    From Robbins LLP
    Via Business Wire
    EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eagle Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    EAGLE PHARMACEUTICALS ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eagle Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    EAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
    From Law Offices of Howard G. Smith
    Via Business Wire
    Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors
    From Kirby McInerney LLP
    Via Business Wire
    Eagle Pharmaceuticals, Inc. (EGRX) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Eagle Pharmaceuticals, Inc.
    From Robbins LLP
    Via Business Wire
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
    From Glancy Prongay & Murray LLP
    Via Business Wire
    EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eagle Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    EGRX CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Eagle Pharmaceuticals, Inc.
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    EGRX CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Eagle Pharmaceuticals, Inc.
    From Glancy Prongay & Murray LLP
    Via Business Wire
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.